Javascript must be enabled to continue!
Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer Data Retrieved from TCGA
View through CrossRef
Abstract
BackgroundImmunotherapy is currently the most advanced anti-tumor treatment approach. The efficacy of anti-tumor immunotherapy is closely related to the tumor immune microenvironment, including immune cells, infiltration of immune factors, and expression of immune checkpoints. At present, the biomarkers for predicting the efficacy of colon cancer immunotherapy do not cover all colon cancer patients suitable for immunotherapy. In this study, TCGA database was used to identify tumor genotypes suitable for anti-tumor immunotherapy. MethodsWe downloaded 390 samples with RNA-sequencing data and somatic mutation status data from TCGA. We applied the ESTIMATE, Package limma, the CIBERSORT and some other algorithms to analyze the cellular immune microenvironment. And validated with immunohistochemistry in tumor tissues of colon cancer patients. ResultsWe found that some of the MSS/pMMR populations, that were initially considered unsuitable for immunotherapy, might actually be suitable. In APC-wt/MSS colon cancer, the expression of PD-1, PD-L1, CTLA4 and CYT(GZMA and PRF1)were increased. Based on calculations done by ESTIMATE and CIBERSORT algorithms, the ImmunoScore and the proportion of CT8+ T cell infiltration is increased in these patients. Enrichment analysis was done to screen signaling pathways involved in immune response, extracellular matrix, and cell adhesion. Tumors from 42 colon cancer patients, including 22 APC-mt/MSS and 20 APC-wt/MSS, were immunohistochemically evaluated for expression of CD8 and PD-L1. And APC-wt/MSS tumors showed significantly higher expression of CD8 and PD-L1 than APC-mt/MSS tumor. ConclusionsBased on the results, we found that some colon cancers of APC-wt/MSS are classified by Tumor Immune Microenvironment types (TIMTs) TMIT I. So that we speculate that APC-wt/MSS colon cancer patients could benefit from anti-tumor immunotherapy.
Springer Science and Business Media LLC
Title: Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer Data Retrieved from TCGA
Description:
Abstract
BackgroundImmunotherapy is currently the most advanced anti-tumor treatment approach.
The efficacy of anti-tumor immunotherapy is closely related to the tumor immune microenvironment, including immune cells, infiltration of immune factors, and expression of immune checkpoints.
At present, the biomarkers for predicting the efficacy of colon cancer immunotherapy do not cover all colon cancer patients suitable for immunotherapy.
In this study, TCGA database was used to identify tumor genotypes suitable for anti-tumor immunotherapy.
MethodsWe downloaded 390 samples with RNA-sequencing data and somatic mutation status data from TCGA.
We applied the ESTIMATE, Package limma, the CIBERSORT and some other algorithms to analyze the cellular immune microenvironment.
And validated with immunohistochemistry in tumor tissues of colon cancer patients.
ResultsWe found that some of the MSS/pMMR populations, that were initially considered unsuitable for immunotherapy, might actually be suitable.
In APC-wt/MSS colon cancer, the expression of PD-1, PD-L1, CTLA4 and CYT(GZMA and PRF1)were increased.
Based on calculations done by ESTIMATE and CIBERSORT algorithms, the ImmunoScore and the proportion of CT8+ T cell infiltration is increased in these patients.
Enrichment analysis was done to screen signaling pathways involved in immune response, extracellular matrix, and cell adhesion.
Tumors from 42 colon cancer patients, including 22 APC-mt/MSS and 20 APC-wt/MSS, were immunohistochemically evaluated for expression of CD8 and PD-L1.
And APC-wt/MSS tumors showed significantly higher expression of CD8 and PD-L1 than APC-mt/MSS tumor.
ConclusionsBased on the results, we found that some colon cancers of APC-wt/MSS are classified by Tumor Immune Microenvironment types (TIMTs) TMIT I.
So that we speculate that APC-wt/MSS colon cancer patients could benefit from anti-tumor immunotherapy.
Related Results
Characterization of the number and site of APC mutations in sporadic colorectal cancer.
Characterization of the number and site of APC mutations in sporadic colorectal cancer.
630 Background: Truncating mutations in the adenomatous polyposis coli ( APC) gene are well-described events in the carcinogenesis of colorectal carcinomas (CRC) and may impact on...
Mortality and morbidity outcomes in patients with inflammatory bowel disease with colon cancer: A nationwide analysis.
Mortality and morbidity outcomes in patients with inflammatory bowel disease with colon cancer: A nationwide analysis.
e15669
Background:
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic condition chara...
Diagnostic accuracy of unenhanced post-mortem CT and MRI compared to the non-forensic clinical autopsy: a prospective blinded study
Diagnostic accuracy of unenhanced post-mortem CT and MRI compared to the non-forensic clinical autopsy: a prospective blinded study
Abstract
The last decades have seen a constant decline in non-forensic clinical autopsy rates worldwide. In this context, post-mortem computed tomography (PMCT) and post-...
P-056 Microfluidic Sperm Selection Enhances Euploidy Rates Compared to Swim-Up in ART
P-056 Microfluidic Sperm Selection Enhances Euploidy Rates Compared to Swim-Up in ART
Abstract
Study question
Is the use of a microfluidic sperm selection (MSS) device associated with higher rates of euploid embryo...
Podoplanin-mediated platelet activation promotes proliferation and invasion of colon cancer cells
Podoplanin-mediated platelet activation promotes proliferation and invasion of colon cancer cells
Abstract
Background: Recent studies have shown that podoplanin is highly expressed in many tumors, suggesting that podoplanin may be related to the invasion and metastasis ...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Role of Antigen‐Presenting Cells in the Cytotoxic T‐Cell Response to Minor Histocompatibility Antigens (MIHA)
Role of Antigen‐Presenting Cells in the Cytotoxic T‐Cell Response to Minor Histocompatibility Antigens (MIHA)
Although antigen‐presenting cells (APC) appear to be able to process minor histocompatibility antigens (MIHA) expressed on allogeneic cells and present them in association with int...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...

